{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:11:41Z","timestamp":1767183101075,"version":"build-2238731810"},"reference-count":52,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"DOI":"10.1542\/pir.30.4.e29","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T03:15:59Z","timestamp":1639192559000},"page":"e29-e33","source":"Crossref","is-referenced-by-count":6,"title":["Complementary, Holistic, and Integrative Medicine"],"prefix":"10.1542","volume":"30","author":[{"given":"Jayna","family":"Brulotte","sequence":"first","affiliation":[{"name":"Complementary and Alternative Research and Education (CARE) Program, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. On behalf of the American Academy of Pediatrics Section on Complementary and Integrative Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Bukutu","sequence":"additional","affiliation":[{"name":"Complementary and Alternative Research and Education (CARE) Program, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. On behalf of the American Academy of Pediatrics Section on Complementary and Integrative Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Vohra","sequence":"additional","affiliation":[{"name":"Complementary and Alternative Research and Education (CARE) Program, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. On behalf of the American Academy of Pediatrics Section on Complementary and Integrative Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"2021121100272385800_R1","unstructured":"National Food Survey Committee. Household Food Consumption and Expenditure 1990 With a Study of Trends of the Period 1940\u20131990. London, United Kingdom: HMSO; 1991"},{"key":"2021121100272385800_R2","doi-asserted-by":"crossref","unstructured":"Sanders TAB. Polyunsaturated fatty acids in the food chain in Europe. Am J Clin Nutr.\u20082000;71:176S\u2013178S","DOI":"10.1093\/ajcn\/71.1.176s"},{"key":"2021121100272385800_R3","doi-asserted-by":"crossref","unstructured":"Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr.\u20082006;83:S1526","DOI":"10.1093\/ajcn\/83.6.1526S"},{"key":"2021121100272385800_R4","unstructured":"Ervin RB, Wright JD, Wang C, Kennedy-Stephenson J. Dietary intake of fats and fatty acids for the United States population: 1999\u20132000. Advance Data.\u20082004;348:1\u20136"},{"key":"2021121100272385800_R5","doi-asserted-by":"crossref","unstructured":"Simopoulos AP. The importance of the ratio of omega-6\/omega-3 essential fatty acids. Biomed Pharmacother.\u20082002;56:365\u2013379","DOI":"10.1016\/S0753-3322(02)00253-6"},{"key":"2021121100272385800_R6","doi-asserted-by":"crossref","unstructured":"Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr.\u20081991;543:438\u2013463","DOI":"10.1093\/ajcn\/54.3.438"},{"key":"2021121100272385800_R7","doi-asserted-by":"crossref","unstructured":"Richardson AJ. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatr.\u20082006;18:155\u2013172","DOI":"10.1080\/09540260600583031"},{"key":"2021121100272385800_R8","doi-asserted-by":"crossref","unstructured":"Richardson AJ, Ross MA. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit\/hyperactivity disorder, dyslexia, dyspraxia, and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids.\u20082000;63:1\u20139","DOI":"10.1054\/plef.2000.0184"},{"key":"2021121100272385800_R9","doi-asserted-by":"crossref","unstructured":"Bell JG, Mackinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen ACA. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leuko Essent Fatty Acids.\u20082004;71:201\u2013204","DOI":"10.1016\/j.plefa.2004.03.008"},{"key":"2021121100272385800_R10","doi-asserted-by":"crossref","unstructured":"Hallahan B, Garland MR. Essential fatty acids and their role in the treatment of impulsivity disorders. Prostaglandins Leukot Essent Fatty Acids.\u20082004;71:211\u2013216","DOI":"10.1016\/j.plefa.2004.03.006"},{"key":"2021121100272385800_R11","doi-asserted-by":"crossref","unstructured":"Pawlosky RJ, Hibbeln JR, Novotny JA, Salem N Jr. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res.\u20082001;42:1257\u20131265","DOI":"10.1016\/S0022-2275(20)31576-5"},{"key":"2021121100272385800_R12","doi-asserted-by":"crossref","unstructured":"Salem N Jr, Pawlosky RJ, Wegher B, Hibbeln JR. In vivo conversion of linoleic acid to arachidonic acid in adult humans. Prostaglandins Leukot Essent Fatty Acids.\u20081999;60:407\u2013410","DOI":"10.1016\/S0952-3278(99)80021-0"},{"key":"2021121100272385800_R13","doi-asserted-by":"crossref","unstructured":"Haag M. Essential fatty acids and the brain. C J Psychiatry.\u20082003;48:203","DOI":"10.1177\/070674370304800308"},{"key":"2021121100272385800_R14","doi-asserted-by":"crossref","unstructured":"Colquhoun I, Bunday S. A lack of essential fatty acids as a possible cause of hyperactivity in children. Med Hypotheses.\u20081981;7:673\u2013679","DOI":"10.1016\/0306-9877(81)90014-1"},{"key":"2021121100272385800_R15","doi-asserted-by":"crossref","unstructured":"Chen JR, Hsu SF, Hsu CD, Hwang LH, Yang SC. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J Nutr Biochem.\u20082004;15:467\u2013472","DOI":"10.1016\/j.jnutbio.2004.01.008"},{"key":"2021121100272385800_R16","doi-asserted-by":"crossref","unstructured":"Colter AL, Cutler C, Meckling KA. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr J.\u20082008;7:8","DOI":"10.1186\/1475-2891-7-8"},{"key":"2021121100272385800_R17","doi-asserted-by":"crossref","unstructured":"Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr.\u20081987;26:406\u2013411","DOI":"10.1177\/000992288702600805"},{"key":"2021121100272385800_R18","doi-asserted-by":"crossref","unstructured":"Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav.\u20081996;59:915\u2013920","DOI":"10.1016\/0031-9384(95)02207-4"},{"key":"2021121100272385800_R19","doi-asserted-by":"crossref","unstructured":"Stevens LJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr.\u20081995;62:761\u2013768","DOI":"10.1093\/ajcn\/62.4.761"},{"key":"2021121100272385800_R20","doi-asserted-by":"crossref","unstructured":"Takeuchi T, Fukumoto Y, Harada E. Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. Behav Brain Res.\u20082002;131:193\u2013203","DOI":"10.1016\/S0166-4328(01)00392-8"},{"key":"2021121100272385800_R21","doi-asserted-by":"crossref","unstructured":"Hirayama S, Hamazaki T, Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit\/hyperactivity disorder\u2013a placebo-controlled double-blind study. Eur J Clin Nutr.\u20082004;58:467\u2013473","DOI":"10.1038\/sj.ejcn.1601830"},{"key":"2021121100272385800_R22","doi-asserted-by":"crossref","unstructured":"Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit\/hyperactivity disorder. J Pediatr.\u20082001;139:189\u2013196","DOI":"10.1067\/mpd.2001.116050"},{"key":"2021121100272385800_R23","doi-asserted-by":"crossref","unstructured":"Richardson AJ, Montgomery P. Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics.\u20082005;115:1360\u20131366","DOI":"10.1542\/peds.2004-2164"},{"key":"2021121100272385800_R24","doi-asserted-by":"crossref","unstructured":"Richardson A, Puri B. The potential role of fatty acids in attention-deficit\/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids.\u20082000;63:79\u201387","DOI":"10.1054\/plef.2000.0196"},{"key":"2021121100272385800_R25","doi-asserted-by":"crossref","unstructured":"Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmaco Biol Psychiatry.\u20082002;26:233\u2013239","DOI":"10.1016\/S0278-5846(01)00254-8"},{"key":"2021121100272385800_R26","doi-asserted-by":"crossref","unstructured":"Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids.\u20082003;38:1007\u20131021","DOI":"10.1007\/s11745-006-1155-0"},{"key":"2021121100272385800_R27","doi-asserted-by":"crossref","unstructured":"Sinn N, Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J Dev Behav Pediatr.\u20082007;28:82\u201391","DOI":"10.1097\/01.DBP.0000267558.88457.a5"},{"key":"2021121100272385800_R28","doi-asserted-by":"crossref","unstructured":"Germano M, Meleleo D, Montorfano G, et al. Plasma, red blood cells, phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD). Nutr Neurosci.\u20082007;10:1\u20139","DOI":"10.1080\/10284150601153801"},{"key":"2021121100272385800_R29","unstructured":"Connors CK. Connors Rating Scales\u2013Revised: Technical Manual. New York, NY: Multi-Health Systems, Inc; 2000"},{"key":"2021121100272385800_R30","doi-asserted-by":"crossref","unstructured":"Clayton EH, Hanstock TL, Garg ML, Hazell PL. Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents. Acta Neuropsychiatr.\u20082007;19:92\u2013103","DOI":"10.1111\/j.1601-5215.2007.00189.x"},{"key":"2021121100272385800_R31","doi-asserted-by":"crossref","unstructured":"Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?Lipids Health Dis.\u20082007;18:6:21","DOI":"10.1186\/1476-511X-6-21"},{"key":"2021121100272385800_R32","doi-asserted-by":"crossref","unstructured":"Baker SM. A biochemical approach to the problem of dyslexia. J Learn Disabil.\u20081985;18:581\u2013584","DOI":"10.1177\/002221948501801003"},{"key":"2021121100272385800_R33","doi-asserted-by":"crossref","unstructured":"Richardson AJ, Calvin CM, Clisby C, et al. Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukot Essent Fatty Acids.\u20082000;63:69\u201374","DOI":"10.1054\/plef.2000.0194"},{"key":"2021121100272385800_R34","doi-asserted-by":"crossref","unstructured":"Lindmark L, Clough P. A 5-month open study with long-chain polyunsaturated fatty acids in dyslexia. J Med Food.\u20082007;10:662\u2013666","DOI":"10.1089\/jmf.2006.399"},{"key":"2021121100272385800_R35","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994"},{"key":"2021121100272385800_R36","doi-asserted-by":"crossref","unstructured":"Gibbs J, Appleton J, Appleton R. Dyspraxia or developmental coordination disorder? Unravelling the enigma. Arch Dis Child.\u20082007;92:534\u2013539","DOI":"10.1136\/adc.2005.088054"},{"key":"2021121100272385800_R37","doi-asserted-by":"crossref","unstructured":"Stordy BJ. Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia. Am J Clin Nutr.\u20082000;71:323S\u2013326S","DOI":"10.1093\/ajcn\/71.1.323S"},{"key":"2021121100272385800_R38","doi-asserted-by":"crossref","unstructured":"Amminger GP, Berger GE, Schafer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acid supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry.\u20082007;61:551\u2013553","DOI":"10.1016\/j.biopsych.2006.05.007"},{"key":"2021121100272385800_R39","doi-asserted-by":"crossref","unstructured":"Curtis LT, Patel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. J Altern Complement Med.\u20082008;14:79\u201385","DOI":"10.1089\/acm.2007.0610"},{"key":"2021121100272385800_R40","doi-asserted-by":"crossref","unstructured":"Vancassel S, Durand G, Barthelemy C, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids.\u20082001;65:1\u20137","DOI":"10.1054\/plef.2001.0281"},{"key":"2021121100272385800_R41","unstructured":"Sliwinski S, Croonenberghs J, Christophe A, Deboutte D, Maes M. Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism?Neuroendocrinol Lett.\u20082006;27:465\u2013471"},{"key":"2021121100272385800_R42","doi-asserted-by":"crossref","unstructured":"Sinn N, Bryan J, Wilson C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. Prostaglandins Leukot Essent Fatty Acids.\u20082008;78:311\u2013326","DOI":"10.1016\/j.plefa.2008.04.004"},{"key":"2021121100272385800_R43","doi-asserted-by":"crossref","unstructured":"Busch B. Polyunsaturated fatty acid supplementation for ADHD? Fishy, fascinating, and far from clear. J Dev Behav Pediatr.\u20082007;28:139\u2013144","DOI":"10.1097\/01.DBP.0000267560.34199.e0"},{"key":"2021121100272385800_R44","doi-asserted-by":"crossref","unstructured":"Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs.\u20082005;65:1051\u20131059","DOI":"10.2165\/00003495-200565080-00002"},{"key":"2021121100272385800_R45","unstructured":"Burrowes JD, Van Houten G. Herbs and dietary supplement use in patients with stage 5 chronic kidney disease. Nephrol Nurs J.\u20082006;33:85\u201388"},{"key":"2021121100272385800_R46","doi-asserted-by":"crossref","unstructured":"Goodnight SH Jr, Harris WS, Connor WE. The effects of dietary omega-3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood.\u20081981;58:880\u2013885","DOI":"10.1182\/blood.V58.5.880.bloodjournal585880"},{"key":"2021121100272385800_R47","doi-asserted-by":"crossref","unstructured":"Wensing AGCL, Mensink RP, Hornstra G. Effects of dietary n-3 polyunsaturated fatty acids from plant and marine origin on platelet aggregation in healthy elderly subjects. Br J Nutr.\u20081999;82:183\u2013191","DOI":"10.1017\/S0007114599001361"},{"key":"2021121100272385800_R48","doi-asserted-by":"crossref","unstructured":"Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis.\u20082003;166:85\u201393","DOI":"10.1016\/S0021-9150(02)00307-6"},{"key":"2021121100272385800_R49","doi-asserted-by":"crossref","unstructured":"Lichtenstein AH. Remarks on clinical data concerning dietary supplements that affect antithrombotic therapy. Thromb Res.\u20082005;117:71\u201373","DOI":"10.1016\/j.thromres.2005.04.013"},{"key":"2021121100272385800_R50","unstructured":"US Food and Drug Administration. GRAS Notice No. GRN 00193. Numerical Listing of GRAS Notices.\u2008http:\/\/www.cfsan.fda.gov\/\u223crdb\/opa-gras.html. Accessed October, 2008"},{"key":"2021121100272385800_R51","doi-asserted-by":"crossref","unstructured":"Foran SE, Flood JG, Lewandrowski KB. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?Arch Pathol Lab Med.\u20082003;127:1603\u20131605","DOI":"10.5858\/2003-127-1603-MOMLIC"},{"key":"2021121100272385800_R52","doi-asserted-by":"crossref","unstructured":"Melanson SF, Lewandrowski EL, Flood JG, Lewandrowski KB. Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature. Arch Pathol Lab Med.\u20082005;129:74\u201377","DOI":"10.5858\/2005-129-74-MOOICO"}],"container-title":["Pediatrics In Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/30\/4\/e29\/1175900\/zpx00409000e29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/30\/4\/e29\/1175900\/zpx00409000e29.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T09:24:00Z","timestamp":1640078640000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article\/30\/4\/e29\/35750\/Complementary-Holistic-and-Integrative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":52,"aliases":["10.1542\/pir.30-4-e29"],"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/pir.30.4.e29","relation":{},"ISSN":["0191-9601","1526-3347"],"issn-type":[{"value":"0191-9601","type":"print"},{"value":"1526-3347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}